Evaluating Auscul-X, a Touch Free Digital Stethoscope

AusculSciences

Status: Unknown

Conditions: COVID-19

Treatments: Device: Auscul-X

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT04570189

Auscul-X

Details and patient eligibility

About

Auscul-X a touch free digital stethoscope will permit physical distancing of healthcare providers while maintaining the ability to auscultate patients from a safe distance (over 10 feet away)

Full description

The Auscul-X System (AusculSciences Canada, Inc.), is novel, professional grade, touch free, multichannel, touch-free electronic stethoscope with disposable elements designed to protect HCPs from exposure to infection diseases by allowing them to auscultate patients from a safe distance (10 feet away). The sensors can stay in place and enable providers to listen on-demand to a patient's heart and lungs over an extended period of time. This practice of distancing in the workplace is a key CDC and PHAC recommendation to protect the frontline HCP from exposure risk to the highly contagious COVID- 19 virus and other communicable diseases. The Auscul-X not only has the potential to better protect HCPs from infection, but also eliminates the potential transmission of pathogens through the use of conventional stethoscopes. In addition, the Auscul-X allows multiple HCPs to listen to the patient's heart and lung sounds simultaneously

Enrollment: 40 estimated patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• >/=18 years old
• Admitted to ICCU and CSICU at UOHI

Exclusion criteria

• Age < 18 years old
• Medically Unstable
• Chest wall deformity or wounds in adhesive application areas
• Unwillingness or inability to provide Informed Consent or to comply with protocol

Trial design

40 participants in 2 patient groups

Phase I

Description:

Twenty subjects, 10 unventilated and 10 ventilated patients, will undergo clinical auscultation of the heart and lungs with the Auscul-X, a conventional stethoscope and an electronic stethoscope (Littmann 3200).

Treatment:

Device: Auscul-X

Phase II

Description:

Twenty subjects, 10 unventilated and 10 ventilated patients, will undergo clinical auscultation of the heart and lungs with an Auscul-X with wireless capability, a conventional stethoscope and an electronic stethoscope (Littmann 3200). Phase II shall begin upon appropriate Health Canada approvals for the Auscul-X with wireless capability.

Treatment:

Device: Auscul-X